ArticleHaematologica2012

Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia?

Dolores J SchendelPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.